You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
維亞生物(01873.HK)預計2021年度收益達20億元 同比增長超180%
格隆匯 03-06 18:50

格隆匯3月6日丨維亞生物(01873.HK)公佈,集團預計2021年度收益將較2020年度增加不少於人民幣13億元或超過180%至約人民幣20億元;預期實現淨利潤不少於人民幣3億元,而2020年度則實現淨虧損人民幣3.79億元。

另外,預計2021年度實現歸屬於公司權益股東的淨利潤不少於人民幣2.8億元,而2020年度則實現歸屬於公司權益股東的淨虧損人民幣3.87億元。集團預計經調整非國際財務報吿準則淨利潤(剔除按公平值列入損益的金融負債的公平值收益、可換股債券債務部分的利息開支、已收購資產的攤銷以及非經常性固定資產處置虧損)不低於人民幣3.5億元,較2020年度上漲不少於38%,主要是因為:

(i)藥物發現服務的收益大幅增加;及(ii)集團業務範圍從前端藥物發現擴展至小分子CDMO業務,形成了藥物研究、開發和生產的一體化平台,且已被按公平值列入損益的金融資產的公平值收益較2020年度的減幅所抵銷。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account